Last reviewed · How we verify
Chronic gouty arthritis
Approved treatments
- Colcrys · Scilex Pharms
Colcrys works by inhibiting the activity of a specific enzyme called serine/threonine-protein kinase pim-1. - Col-Probenecid · Pfizer Inc.
ORLYNVAH combines sulopenem etzadroxil, a penem antibacterial, with probenecid to increase sulopenem's plasma concentration by inhibiting its renal clearance.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic gouty arthritis patent landscape — cliff calendar, originator estates, attackable patents
- Chronic gouty arthritis treatment landscape brief
- Chronic gouty arthritis treatment updates RSS
Frequently asked questions about Chronic gouty arthritis
What drugs treat Chronic gouty arthritis?
Tracked treatments include Colcrys, Col-Probenecid.
What is the treatment for Chronic gouty arthritis?
Standard treatment for Chronic gouty arthritis includes Colcrys, Col-Probenecid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic gouty arthritis patent cliff · Chronic gouty arthritis CI report
- Treatment: Colcrys · Scilex Pharms
- Treatment: Col-Probenecid · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing